Abstract Introduction Reducing dosing frequency may lower treatment burden and improve persistence and adherence
You should list all relevant diagnoses with their ICD-10 codes in section 2
Both can cause nausea, GI upset, or constipation, but I see liraglutide patients more often report daily low-grade nausea, whereas semaglutide tends to cause more pronounced symptoms early on that taper with dose titration
BAC water is sold separately
If you suspect you have experienced an adverse reaction to a GLP-1 receptor agonist, including gallbladder problems, you can report this through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or via the Yellow Card app)
Follow-up and outcomes After implementing the recommendations including SZRT, the patient reported improved sleep quality, fewer nighttime awakenings, and feeling more rested